Home
>
National Drug Code (NDC)
>
NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
NOEVIR 5 TREATMENT LIQUID FOUNDATION LX - 62908-013-02 - (OCTINOXATE, TITANIUM DIOXIDE)
Drug Information of NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
| Product NDC: | 62908-013 |
| Proprietary Name: | NOEVIR 5 TREATMENT LIQUID FOUNDATION LX |
| Non Proprietary Name: | OCTINOXATE, TITANIUM DIOXIDE |
| Active Ingredient(s): | 1000; 7490 mg/100g; mg/100g & nbsp; OCTINOXATE, TITANIUM DIOXIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
| Product NDC: | 62908-013 |
| Labeler Name: | NOEVIR USA INC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20100801 |
Package Information of NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
| Package NDC: | 62908-013-02 |
| Package Description: | 1 TUBE in 1 BOX (62908-013-02) > 38 g in 1 TUBE (62908-013-01) |
NDC Information of NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
| NDC Code | 62908-013-02 |
| Proprietary Name | NOEVIR 5 TREATMENT LIQUID FOUNDATION LX |
| Package Description | 1 TUBE in 1 BOX (62908-013-02) > 38 g in 1 TUBE (62908-013-01) |
| Product NDC | 62908-013 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | OCTINOXATE, TITANIUM DIOXIDE |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20100801 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | NOEVIR USA INC |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
| Strength Number | 1000; 7490 |
| Strength Unit | mg/100g; mg/100g |
| Pharmaceutical Classes |
